The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology
Open accessAbstract
Myofibre necrosis is a central pathogenic process in muscular dystrophies (MD). As post-lesional regeneration cannot fully compensate for chronic myofibre loss, interstitial tissue accumulates and impairs muscle function. Muscle regeneration has been extensively studied over the last decades, however, the pathway(s) controlling muscle necrosis remains largely unknown. The recent discovery of several regulated cell death (RCD) pathways with necrotic morphology challenged the dogma of necrosis as an uncontrolled process, opening interesting perspectives for many degenerative disorders. In this review, we focus on how cell death affects myofibres in MDs, integrating the latest research in the cell death field, with specific emphasis on Duchenne muscular dystrophy, the best-known and most common hereditary MD. The role of regulated forms of necrosis in myology is still in its infancy but there is increasing evidence that necroptosis, a genetically programmed form of necrosis, is involved in muscle degenerating disorders. The existence of apoptosis in myofibre demise will be questioned, while other forms of non-apoptotic RCDs may also have a role in myonecrosis, illustrating the complexity and possibly the heterogeneity of the cell death pathways in muscle degenerating conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Local and systemic toxicity due to snakebite envenomation is primarily driven by cytotoxic venom components that affect cell viability and extracellular matrix degradation [4,26].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disruption of intracellular ion balance, particularly calcium ion imbalance, is a hallmark of venom-induced toxicity [26].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cellular responses then lead to a point of no return that transitions from sublethal cellular injury to a defined form of regulated cell death (RCD), such as apoptosis, ferroptosis, and pyroptosis [26].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nalbandian, A., Khan, A. A., Srivastava, R., Llewellyn, K. J., Tan, B., Shukr, N., Fazli, Y., Kimonis, V. E., & BenMohamed, L. (2016) · Inflammation · doi:10.1007/s10753-016-0449-5 · Cited by 42
RetractedApoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Munoz, C., Elvira, B., Towhid, S. T., Alesutan, I., Shumilina, E., Bock, C.-T., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350083 · Cited by 8,675
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
SATELLITE CELL OF SKELETAL MUSCLE FIBERS
Mauro, A. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.9.2.493 · Cited by 3,683 · cited 1×
“MuSCs are usually found in a quiescent state, beside myofibers and underneath the basal lamina of myofibres basal lamina [3].”
BackgroundMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Regulation of cell death: the calcium–apoptosis link
Orrenius, S., Zhivotovsky, B., & Nicotera, P. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1150 · Cited by 3,012
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
The molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70271-6 · Cited by 2,053 · cited 2×
“This includes benefits in muscle strength [54], prolonged walking capacity [55], and delayed respiratory insufficiency [33,34].”
BackgroundPrevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002 · cited 2×
“Furthermore, studies show that depletion of inflammatory cells can impair muscle healing in vivo [7,8].”
BackgroundRIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931
Genetic control of programmed cell death in the nematode C. elegans
Ellis, H. (1986) · Cell · doi:10.1016/0092-8674(86)90004-8 · Cited by 1,828
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735 · cited 2×
“Several death pathways have now been identified, collectively referred to as regulated necrosis (RN) or non-apoptotic regulated cell death (RCD) [14].”
BackgroundImmunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L.-F., Wang, F.-S., & Wang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.003 · Cited by 1,563
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526 · cited 2×
“Furthermore, given the scaffolding role of Dystrophin in myofibres, a greater susceptibility to mechanical stress during contractions occurs [2], which is exacerbated in eccentric contractions [44,45].”
BackgroundFridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
Birnkrant, D. J., Bushby, K., Bann, C. M., Alman, B. A., Apkon, S. D., Blackwell, A., Case, L. E., Cripe, L., Hadjiyannakis, S., Olson, A. K., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30025-5 · Cited by 1,167 · cited 2×
“This includes benefits in muscle strength [54], prolonged walking capacity [55], and delayed respiratory insufficiency [33,34].”
BackgroundKraupp, B. G., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., & Schulte-Hermann, R. (1995) · Hepatology · doi:10.1002/hep.1840210534 · Cited by 1,156
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Müller, C. R., Lindlöf, M., Kääriäinen, H. A., et al. (1989) · Europe PMC (PubMed Central) · Cited by 1,113
Regulatory interactions between muscle and the immune system during muscle regeneration
Tidball, J. G., & Villalta, S. A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00735.2009 · Cited by 1,105 · cited 1×
“Following muscle damage, the infiltration of inflammatory cells such as neutrophils and macrophages, although promote injury, can initiate a recovery in damaged muscle cells through tissue healing [5,6].”
BackgroundInfluentialInflammasome Complexes: Emerging Mechanisms and Effector Functions
Rathinam, V. A. K., & Fitzgerald, K. A. (2016) · Cell · doi:10.1016/j.cell.2016.03.046 · Cited by 1,101
Defective membrane repair in dysferlin-deficient muscular dystrophy
Bansal, D., Miyake, K., Vogel, S. S., Groh, S., Chen, C.-C., Williamson, R., McNeil, P. L., & Campbell, K. P. (2003) · Nature · doi:10.1038/nature01573 · Cited by 1,022 · cited 1×
“In line with previously mentioned MDs, dysferlinopathy is characterized by muscle degenerating features and inflammatory infiltrate [100,101].”
BackgroundEssential versus accessory aspects of cell death: recommendations of the NCCD 2015
Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.137 · Cited by 1,002
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Brenman, J. E., Chao, D. S., Xia, H., Aldape, K., & Bredt, D. S. (1995) · Cell · doi:10.1016/0092-8674(95)90471-9 · Cited by 961 · cited 1×
“It also affects nitric oxide (NO) synthase expression and localization [46], indirectly playing roles in intracellular signalling of dystrophic myofibre (for review, see [47]).”
BackgroundToll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
Kaiser, W. J., Sridharan, H., Huang, C., Mandal, P., Upton, J. W., Gough, P. J., Sehon, C. A., Marquis, R. W., Bertin, J., & Mocarski, E. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462341 · Cited by 959
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C.-Y., & Baldwin Jr., A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 924 · cited 1×
“In a dose-dependent manner, TNFα is required for MuSC differentiation via p38 MAPK pathway [64], while it prevents differentiation and promotes atrophy via NFκB activation [65].”
BackgroundLiu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J. A., Hentati, F., Hamida, M. B., et al. (1998) · Nature Genetics · doi:10.1038/1682 · Cited by 924 · cited 1×
“In humans, dysferlin mutations can lead to different forms of MD including Miyoshi myopathy and Limb-Girdle Muscular Dystrophy type 2B [99].”
BackgroundCritical role for calcium mobilization in activation of the NLRP3 inflammasome
Murakami, T., Ockinger, J., Yu, J., Byles, V., McColl, A., Hofer, A. M., & Horng, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117765109 · Cited by 923
Cell death modalities: classification and pathophysiological implications
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402148 · Cited by 832
Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K., Zhou, Z., Rubens, J., Hetz, C., Danial, N. N., Moskowitz, M. A., & Korsmeyer, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505294102 · Cited by 820
Julien, O., & Wells, J. A. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.44 · Cited by 816
Upton, J. W., Kaiser, W. J., & Mocarski, E. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.016 · Cited by 758
Aartsma‐Rus, A., Van Deutekom, J. C. T., Fokkema, I. F., Van Ommen, G. B., & Den Dunnen, J. T. (2006) · Muscle & Nerve · doi:10.1002/mus.20586 · Cited by 739
He, S., Liang, Y., Shao, F., & Wang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116302108 · Cited by 729
Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features
Berghe, T. V., Vanlangenakker, N., Parthoens, E., Deckers, W., Devos, M., Festjens, N., Guerin, C. J., Brunk, U. T., Declercq, W., & Vandenabeele, P. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.184 · Cited by 639
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630 · cited 3×
“Therefore the complexity and pleiotropy of RCDs should be taken into consideration when evaluating the therapeutic activity of drugs in experimental disease models, and then in clinics [16].”
BackgroundInfluentialTissue macrophages: heterogeneity and functions
Gordon, S., & Plüddemann, A. (2017) · BMC Biology · doi:10.1186/s12915-017-0392-4 · Cited by 603 · cited 1×
“Following muscle damage, the infiltration of inflammatory cells such as neutrophils and macrophages, although promote injury, can initiate a recovery in damaged muscle cells through tissue healing [5,6].”
BackgroundInfluentialCaspase 3 activity is required for skeletal muscle differentiation
Fernando, P., Kelly, J. F., Balazsi, K., Slack, R. S., & Megeney, L. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162172899 · Cited by 552
Mercuri, E., Bönnemann, C. G., & Muntoni, F. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32910-1 · Cited by 551 · cited 9×
“Necroinflammation is significant in sarcoglycanopathies [21].”
BackgroundInfluentialCleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis
Newton, K., Wickliffe, K. E., Dugger, D. L., Maltzman, A., Roose-Girma, M., Dohse, M., Kőműves, L., Webster, J. D., & Dixit, V. M. (2019) · Nature · doi:10.1038/s41586-019-1548-x · Cited by 539
Activation of Necroptosis in Multiple Sclerosis
Ofengeim, D., Ito, Y., Najafov, A., Zhang, Y., Shan, B., DeWitt, J. P., Ye, J., Zhang, X., Chang, A., Vakifahmetoglu-Norberg, H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.051 · Cited by 526
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Fenichel, G. M., Miller, J. P., King, W., Signore, L., Pandya, S., Florence, J., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202405 · Cited by 520 · cited 1×
“This includes benefits in muscle strength [54], prolonged walking capacity [55], and delayed respiratory insufficiency [33,34].”
BackgroundVillalta, S. A., Nguyen, H. X., Deng, B., Gotoh, T., & Tidball, J. G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn376 · Cited by 512 · cited 1×
“IFNγ is also upregulated in degenerating mdx muscles [73,74], thus it was originally hypothesized that IFNγ could actively take part in myonecrosis, either directly or indirectly via its promotion of a pro-inflammatory environment in muscle.”
BackgroundMitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency
Irwin, W. A., Bergamin, N., Sabatelli, P., Reggiani, C., Megighian, A., Merlini, L., Braghetta, P., Columbaro, M., Volpin, D., Bressan, G. M., et al. (2003) · Nature Genetics · doi:10.1038/ng1270 · Cited by 509
Comparative Study of Injury Models for Studying Muscle Regeneration in Mice
Hardy, D., Besnard, A., Latil, M., Jouvion, G., Briand, D., Thépenier, C., Pascal, Q., Guguin, A., Gayraud-Morel, B., Cavaillon, J.-M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147198 · Cited by 509
Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis
Eskandari, E., & Eaves, C. J. (2022) · Journal of Cell Biology · doi:10.1083/jcb.202201159 · Cited by 495
Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation
Wang, J., & Walsh, K. (1996) · Science · doi:10.1126/science.273.5273.359 · Cited by 489
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
Straub, V., Rafael, J. A., Chamberlain, J. S., & Campbell, K. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.375 · Cited by 488 · cited 1×
“Direct consequences of leaky sarcolemma myonecrosis include an increase of creatine kinase (CK) release in the blood (hyperCKmia), the uptake of proteins belonging to the blood compartment into leaky myofibres [23], associated with typical inflammatory consequences of necrotic demise.”
BackgroundRIP1, a kinase on the crossroads of a cell's decision to live or die
Festjens, N., Vanden Berghe, T., Cornelis, S., & Vandenabeele, P. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402085 · Cited by 468
Homeostasis-altering molecular processes as mechanisms of inflammasome activation
Liston, A., & Masters, S. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.151 · Cited by 459
Turner, P. R., Westwood, T., Regen, C. M., & Steinhardt, R. A. (1988) · Nature · doi:10.1038/335735a0 · Cited by 456
Allen, D. G., Whitehead, N. P., & Froehner, S. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00007.2015 · Cited by 426 · cited 1×
“It also affects nitric oxide (NO) synthase expression and localization [46], indirectly playing roles in intracellular signalling of dystrophic myofibre (for review, see [47]).”
BackgroundNecroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS
Re, D. B., Le Verche, V., Yu, C., Amoroso, M. W., Politi, K. A., Phani, S., Ikiz, B., Hoffmann, L., Koolen, M., Nagata, T., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.011 · Cited by 406
Lockshin, R. A., & Williams, C. M. (1964) · Journal of Insect Physiology · doi:10.1016/0022-1910(64)90034-4 · Cited by 397
Palacios, D., Mozzetta, C., Consalvi, S., Caretti, G., Saccone, V., Proserpio, V., Marquez, V. E., Valente, S., Mai, A., Forcales, S. V., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.013 · Cited by 392 · cited 1×
“TNFα has also been identified as mitogenic for MuSC in vitro and in vivo [66,67].”
BackgroundPerspectives on skeletal muscle stem cells
Relaix, F., Bencze, M., Borok, M. J., Der Vartanian, A., Gattazzo, F., Mademtzoglou, D., Perez-Diaz, S., Prola, A., Reyes-Fernandez, P. C., Rotini, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20760-6 · Cited by 387 · cited 1×
“In parallel, a subpopulation of proliferating MuSCs participates in the renewal of a pool of quiescent MuSCs by relocating into satellite cell niches so that further regenerative events can be achieved in case of injury (For review, see [4]).”
BackgroundSelf-citationSamson, A. L., Zhang, Y., Geoghegan, N. D., Gavin, X. J., Davies, K. A., Mlodzianoski, M. J., Whitehead, L. W., Frank, D., Garnish, S. E., Fitzgibbon, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16887-1 · Cited by 362
Sharp, N. J. H., Kornegay, J. N., Van Camp, S. D., Herbstreith, M. H., Secore, S. L., Kettle, S., Hung, W.-Y., Constantinou, C. D., Dykstra, M. J., Roses, A. D., et al. (1992) · Genomics · doi:10.1016/0888-7543(92)90210-j · Cited by 362 · cited 1×
“These include mouse [36,37], dog [38], pig [39], rabbit [40], and rat [41–43] species.”
BackgroundMillay, D. P., Sargent, M. A., Osinska, H., Baines, C. P., Barton, E. R., Vuagniaux, G., Sweeney, H. L., Robbins, J., & Molkentin, J. D. (2008) · Nature Medicine · doi:10.1038/nm1736 · Cited by 361
Transcription-independent p53 apoptosis: an alternative route to death
Speidel, D. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.10.002 · Cited by 356
Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
Duclos, F., Straub, V., Moore, S. A., Venzke, D. P., Hrstka, R. F., Crosbie, R. H., Durbeej, M., Lebakken, C. S., Ettinger, A. J., van der Meulen, J., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.6.1461 · Cited by 356
COULTON, G. R., MORGAN, J. E., PARTRIDGE, T. A., & SLOPER, J. C. (1988) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1988.tb00866.x · Cited by 344 · cited 1×
“These include mouse [36,37], dog [38], pig [39], rabbit [40], and rat [41–43] species.”
BackgroundDiagnostic approach to the congenital muscular dystrophies
Bönnemann, C. G., Wang, C. H., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Béroud, C., Mathews, K. D., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.12.011 · Cited by 340
Vanlangenakker, N., Vanden Berghe, T., Bogaert, P., Laukens, B., Zobel, K., Deshayes, K., Vucic, D., Fulda, S., Vandenabeele, P., & Bertrand, M. J. M. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.138 · Cited by 339
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein
Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Mattéotti, C., Arias, C., Corona, E. D., Nuñez, N. G., Leo, O., et al. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.04.002 · Cited by 339
Muscle as a paracrine and endocrine organ
Giudice, J., & Taylor, J. M. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.05.005 · Cited by 331 · cited 1×
“Beyond its crucial function in locomotion, it also has important roles in body homeostasis, such as the regulation of body temperature and hormonal activity [1].”
BackgroundMyonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining
Bruusgaard, J. C., Johansen, I. B., Egner, I. M., Rana, Z. A., & Gundersen, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913935107 · Cited by 327
Cornelison, D. D. W., Wilcox-Adelman, S. A., Goetinck, P. F., Rauvala, H., Rapraeger, A. C., & Olwin, B. B. (2004) · Genes & Development · doi:10.1101/gad.1214204 · Cited by 317
Luedde, M., Lutz, M., Carter, N., Sosna, J., Jacoby, C., Vucur, M., Gautheron, J., Roderburg, C., Borg, N., Reisinger, F., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu146 · Cited by 315
Brack, A. S., Bildsoe, H., & Hughes, S. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02602 · Cited by 306
TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK
Chen, S.-E., Jin, B., & Li, Y.-P. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00486.2006 · Cited by 301 · cited 1×
“In a dose-dependent manner, TNFα is required for MuSC differentiation via p38 MAPK pathway [64], while it prevents differentiation and promotes atrophy via NFκB activation [65].”
BackgroundHamer, P. W., McGeachie, J. M., Davies, M. J., & Grounds, M. D. (2002) · Journal of Anatomy · doi:10.1046/j.0021-8782.2001.00008.x · Cited by 297 · cited 1×
“Furthermore, given the scaffolding role of Dystrophin in myofibres, a greater susceptibility to mechanical stress during contractions occurs [2], which is exacerbated in eccentric contractions [44,45].”
BackgroundMUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIES
Whitehead, N. P., Yeung, E. W., & Allen, D. G. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04394.x · Cited by 293 · cited 1×
“A hallmark of dystrophin-deficient cells is the dysregulation of calcium homeostasis and an increase of cytosolic calcium levels, with consequences on the activation of protease systems such as calpains [13,79].”
BackgroundPhillips, T., & Leeuwenburgh, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2870fje · Cited by 283
Apoptosis-based therapies and drug targets
Fischer, U., & Schulze-Osthoff, K. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401556 · Cited by 282
Baghdiguian, S., Martin, M., Richard, I., Pons, F., Astier, C., Bourg, N., Hay, R. T., Chemaly, R., Halaby, G., Loiselet, J., et al. (1999) · Nature Medicine · doi:10.1038/8385 · Cited by 278
Inflammation induced loss of skeletal muscle
Londhe, P., & Guttridge, D. C. (2015) · Bone · doi:10.1016/j.bone.2015.03.015 · Cited by 276 · cited 1×
“Several inflammatory cytokines such as TNFα, IFNγ, and TNF-like weak inducer of apoptosis (TWEAK) are ligands to the tumour necrosis factor receptor (TNFR) family and are upregulated in dystrophin-deficient muscles [62].”
BackgroundIwata, Y., Katanosaka, Y., Arai, Y., Komamura, K., Miyatake, K., & Shigekawa, M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200301101 · Cited by 273 · cited 1×
“6 myotubes from δ-SG-deficient hamsters with basal increased opening probabilities and decreased closed times [95], which is mediated by transient receptor potential cation channel subfamily V, member 2 (TRPV2) [96].”
BackgroundLong‐term benefit from prednisone therapy in Duchenne muscular dystrophy
Fenichel, G. M., Florence, J. M., Pestronk, A., Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Miller, J. P., Robison, J., King, W., et al. (1991) · Neurology · doi:10.1212/wnl.41.12.1874 · Cited by 263 · cited 1×
“This includes benefits in muscle strength [54], prolonged walking capacity [55], and delayed respiratory insufficiency [33,34].”
BackgroundRicotti, V., Ridout, D. A., Scott, E., Quinlivan, R., Robb, S. A., Manzur, A. Y., Muntoni, F., on behalf of the NorthStar Clinical Network, Manzur, A., Muntoni, F., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303902 · Cited by 263 · cited 1×
“GCs, by intermittent and daily intake, are so far the only pharmacological treatment which provide significant improvement in skeletal muscle weakness and slows down the course of pathogenesis [53].”
BackgroundCyclosporine-Induced Hyperuricemia and Gout
Lin, H.-Y., Rocher, L. L., McQuillan, M. A., Schmaltz, S., Palella, T. D., & Fox, I. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210504 · Cited by 250
TNF-α is a mitogen in skeletal muscle
Li, Y.-P. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00453.2002 · Cited by 249 · cited 1×
“TNFα has also been identified as mitogenic for MuSC in vitro and in vivo [66,67].”
BackgroundWallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppee, F., Ladner, K. J., Guttridge, D., Yang, J., & Harper, S. Q. (2011) · Annals of Neurology · doi:10.1002/ana.22275 · Cited by 240
Apoptosis precedes necrosis of dystrophin-deficient muscle
Tidball, J. G., Albrecht, D. E., Lokensgard, B. E., & Spencer, M. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2197 · Cited by 236
Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis
Grounds, M. D., & Torrisi, J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1024com · Cited by 235 · cited 1×
“TNF-elicited cell death is particularly efficient at the onset of mdx pathogenesis, when muscle degeneration is at its highest [68,69].”
BackgroundThe Role of Oxidative Stress in Skeletal Muscle Myogenesis and Muscle Disease
Lian, D., Chen, M.-M., Wu, H., Deng, S., & Hu, X. (2022) · Antioxidants · doi:10.3390/antiox11040755 · Cited by 232 · cited 1×
“Reactive oxygen species (ROS) are often associated with myofibre death [25,26], even if their precise role in pathogenesis remains unclear as ROS can be generated by cells submitted to sublethal or lethal stress [27].”
BackgroundHodgetts, S., Radley, H., Davies, M., & Grounds, M. D. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.06.011 · Cited by 227 · cited 1×
“TNF-elicited cell death is particularly efficient at the onset of mdx pathogenesis, when muscle degeneration is at its highest [68,69].”
BackgroundCalpains Are Activated in Necrotic Fibers from mdx Dystrophic Mice
Spencer, M. J., Croall, D. E., & Tidball, J. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10909 · Cited by 216
Caspase Inhibitors Promote Alternative Cell Death Pathways
Vandenabeele, P., Vanden Berghe, T., & Festjens, N. (2006) · Science's STKE · doi:10.1126/stke.3582006pe44 · Cited by 215
Brouckaert, G., Kalai, M., Krysko, D. V., Saelens, X., Vercammen, D., Ndlovu, `., Haegeman, G., D'Herde, K., & Vandenabeele, P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0668 · Cited by 209
Durbeej, M., Cohn, R. D., Hrstka, R. F., Moore, S. A., Allamand, V., Davidson, B. L., Williamson, R. A., & Campbell, K. P. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80410-4 · Cited by 209
Apoptosis in muscle atrophy: Relevance to sarcopenia
Dupont-Versteegden, E. E. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.04.003 · Cited by 207
Muscle cells from mdx mice have an increased susceptibility to oxidative stress
Rando, T. A., Disatnik, M.-H., Yu, Y., & Franco, A. (1998) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00124-7 · Cited by 207
Genetic Background Affects Properties of Satellite Cells and mdx Phenotypes
Fukada, S.-I., Morikawa, D., Yamamoto, Y., Yoshida, T., Sumie, N., Yamaguchi, M., Ito, T., Miyagoe-Suzuki, Y., Takeda, S., Tsujikawa, K., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090887 · Cited by 207 · cited 1×
“These include mouse [36,37], dog [38], pig [39], rabbit [40], and rat [41–43] species.”
BackgroundBartoli, M., & Richard, I. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.12.012 · Cited by 198 · cited 1×
“Dysregulation of calpains activation correlates with disease extent (see review [80]).”
BackgroundCharacterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy
Larcher, T., Lafoux, A., Tesson, L., Remy, S., Thepenier, V., François, V., Le Guiner, C., Goubin, H., Dutilleul, M., Guigand, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110371 · Cited by 197
Flipping the dogma – phosphatidylserine in non-apoptotic cell death
Shlomovitz, I., Speir, M., & Gerlic, M. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0437-0 · Cited by 189
Cell death in denervated skeletal muscle is distinct from classical apoptosis
Borisov, A. B., & Carlson, B. M. (2000) · The Anatomical Record · doi:10.1002/(sici)1097-0185(20000301)258:3<292::aid-ar9>3.0.co;2-n · Cited by 178
Bencze, M., Négroni, E., Vallese, D., Yacoub‐Youssef, H., Chaouch, S., Wolff, A., Aamiri, A., Santo, J. P. D., Chazaud, B., Butler-Browne, G. S., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.189 · Cited by 178 · cited 2×
“Furthermore, studies show that depletion of inflammatory cells can impair muscle healing in vivo [7,8].”
BackgroundSelf-citationRegulated cell death and adaptive stress responses
Galluzzi, L., Bravo-San Pedro, J. M., Kepp, O., & Kroemer, G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2209-y · Cited by 177 · cited 1×
“As a consequence, TNFα can control cell proliferation, differentiation, or metabolism, either positively or negatively, and trigger cell death, depending on the cellular context which allows the balance between pro-death and pro-survival machinery [63].”
BackgroundMyonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
Spencer, M. J., Walsh, C. M., Dorshkind, K. A., Rodriguez, E. M., & Tidball, J. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119464 · Cited by 177
MLKL Requires the Inositol Phosphate Code to Execute Necroptosis
Dovey, C. M., Diep, J., Clarke, B. P., Hale, A. T., McNamara, D. E., Guo, H., Brown, N. W., Cao, J. Y., Grace, C. R., Gough, P. J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.010 · Cited by 175
Klymiuk, N., Blutke, A., Graf, A., Krause, S., Burkhardt, K., Wuensch, A., Krebs, S., Kessler, B., Zakhartchenko, V., Kurome, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt287 · Cited by 175 · cited 1×
“These include mouse [36,37], dog [38], pig [39], rabbit [40], and rat [41–43] species.”
BackgroundGeneration of muscular dystrophy model rats with a CRISPR/Cas system
Nakamura, K., Fujii, W., Tsuboi, M., Tanihata, J., Teramoto, N., Takeuchi, S., Naito, K., Yamanouchi, K., & Nishihara, M. (2014) · Scientific Reports · doi:10.1038/srep05635 · Cited by 175
Inflammasome Up-Regulation and Activation in Dysferlin-Deficient Skeletal Muscle
Rawat, R., Cohen, T. V., Ampong, B., Francia, D., Henriques-Pons, A., Hoffman, E. P., & Nagaraju, K. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090058 · Cited by 175
Cell death in denervated skeletal muscle is distinct from classical apoptosis
Borisov, A. B., & Carlson, B. M. (2000) · The Anatomical Record · doi:10.1002/(sici)1097-0185(20000301)258:3<305::aid-ar10>3.0.co;2-a · Cited by 172
Staying Alive: Cell Death in Antiviral Immunity
Upton, J. W., & Chan, F. K.-M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.01.027 · Cited by 171
Efferocytosis and Its Role in Inflammatory Disorders
Ge, Y., Huang, M., & Yao, Y.-M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839248 · Cited by 165
Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies
Mareedu, S., Million, E. D., Duan, D., & Babu, G. J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.647010 · Cited by 164 · cited 1×
“For example, abnormal Ca2+ influx has been extensively investigated in dystrophin-deficient myotubes [48].”
BackgroundLovering, R. M., & De Deyne, P. G. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00199.2003 · Cited by 161 · cited 1×
“Furthermore, given the scaffolding role of Dystrophin in myofibres, a greater susceptibility to mechanical stress during contractions occurs [2], which is exacerbated in eccentric contractions [44,45].”
BackgroundAraishi, K., Sasaoka, T., Imamura, M., Noguchi, S., Hama, H., Wakabayashi, E., Yoshida, M., Hori, T., & Ozawa, E. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1589 · Cited by 161
Villalta, S. A., Deng, B., Rinaldi, C., Wehling-Henricks, M., & Tidball, J. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101267 · Cited by 158 · cited 1×
“The null mutation of IFNγ does indeed ameliorate muscle function in mdx mice without preventing myofibre death or necroinflammation [75], suggesting an overall detrimental role of IFNγ in the myogenesis of mdx muscle.”
BackgroundDavies, J. E., Wang, L., Garcia-Oroz, L., Cook, L. J., Vacher, C., O'Donovan, D. G., & Rubinsztein, D. C. (2005) · Nature Medicine · doi:10.1038/nm1242 · Cited by 158
Alderton, J. M., & Steinhardt, R. A. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00075-x · Cited by 157
Muscle pathology in dysferlin deficiency
Fanin, M., & Angelini, C. I. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00417.x · Cited by 156
NF-κB Protects Cells from Gamma Interferon-Induced RIP1-Dependent Necroptosis
Thapa, R. J., Basagoudanavar, S. H., Nogusa, S., Irrinki, K. M., Mallilankaraman, K. B., Slifker, M. J., Beg, A. A., Madesh, M., & Balachandran, S. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05445-11 · Cited by 151
Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy
Quattrocelli, M., Barefield, D. Y., Warner, J. L., Vo, A. H., Hadhazy, M., Earley, J. U., Demonbreun, A. R., & McNally, E. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91445 · Cited by 151
An outline of necrosome triggers
Berghe, T. V., Hassannia, B., & Vandenabeele, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2189-y · Cited by 150
Aging influences cellular and molecular responses of apoptosis to skeletal muscle unloading
Siu, P. M., Pistilli, E. E., Butler, D. C., & Alway, S. E. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00239.2004 · Cited by 145
Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
Grounds, M. D., Terrill, J. R., Al-Mshhdani, B. A., Duong, M. N., Radley‐Crabb, H. G., & Arthur, P. G. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.043638 · Cited by 143
Oxidative damage to muscle protein in Duchenne muscular dystrophy
Haycock, J. W., Neil, S. M., Jones, P., Harris, J. B., & Mantle, D. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00070 · Cited by 142
Dysferlin Deficiency Enhances Monocyte Phagocytosis
Nagaraju, K., Rawat, R., Veszelovszky, E., Thapliyal, R., Kesari, A., Sparks, S. E., Raben, N., Plötz, P. H., & Hoffman, E. P. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070327 · Cited by 141
Sandri, M., MESSLEMANI, A. H. E., Sandri, C., Schjerling, P., Vissing, K., Andersen, J. L., Rossini, K., Carraro, U., & Angelini, C. I. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.3.302 · Cited by 139
Evolution of caspase-mediated cell death and differentiation: twins separated at birth
Bell, R. A. V., & Megeney, L. A. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.37 · Cited by 134
Langenbach, K. J., & Rando, T. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10258 · Cited by 128
McLoon, L. K., Rowe, J., Wirtschafter, J. D., & McCormick, K. M. (2004) · Muscle & Nerve · doi:10.1002/mus.20012 · Cited by 126
Muscle degeneration without mechanical injury in sarcoglycan deficiency
Hack, A. A., Cordier, L., Shoturma, D. I., Lam, M. Y., Sweeney, H. L., & McNally, E. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10723 · Cited by 126
Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster
Straub, V. W., Duclos, F. J., Venzke, D. P., Lee, J. C., Cutshall, S., Leveille, C. J., & Campbell, K. P. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65751-3 · Cited by 125 · cited 1×
“Despite knowledge of gene variants involved, the main putative cause of myofibre death of SG-deficient muscle is the loss of membrane integrity caused by mechanical stress in the context of DAPC default [91].”
BackgroundBurr, A. R., & Molkentin, J. D. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.65 · Cited by 121
Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy
Girgenrath, M., Dominov, J. A., Kostek, C. A., & Miller, J. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22928 · Cited by 119
Mitochondrial regulation of cell death: a phylogenetically conserved control
Galluzzi, L., Kepp, O., & Kroemer, G. (2016) · Microbial Cell · doi:10.15698/mic2016.03.483 · Cited by 118
Reutenauer, J., Dorchies, O. M., Patthey-Vuadens, O., Vuagniaux, G., & Rüegg, U. T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.285 · Cited by 117
Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter
Picón, C., Jayaraman, A., James, R., Beck, C., Gallego, P., Witte, M. E., van Horssen, J., Mazarakis, N. D., & Reynolds, R. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02274-7 · Cited by 117
Oliveira, J., Gruber, A. J., Cardoso, M. N., Taipa, R. J. F., Fineza, I., Gonçalves, A., Laner, A., Winder, T. L., Schroeder, J. A., Rath, J., et al. (2018) · Human Mutation · doi:10.1002/humu.23599 · Cited by 115
Activated Satellite Cells in Extraocular Muscles of Normal Adult Monkeys and Humans
McLoon, L. K., & Wirtschafter, J. D. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0673 · Cited by 115
Necroptosis mediates myofibre death in dystrophin-deficient mice
Morgan, J. E., Prola, A., Mariot, V., Pini, V., Meng, J., Hourdé, C., Dumonceaux, J., Conti, F. J. A., Relaix, F., Authier, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06057-9 · Cited by 114 · cited 5×
“Indeed, apoptotic-like myonuclei are relatively rare in degenerating dystrophic muscles [18,165].”
BackgroundInfluentialSelf-citationIs caspase‐dependent apoptosis only cell differentiation taken to the extreme?
Fernando, P., & Megeney, L. A. (2006) · The FASEB Journal · doi:10.1096/fj.06-5912hyp · Cited by 112
Apoptotic myonuclei in human Duchenne muscular dystrophy.
Sandri, M., Minetti, C., Pedemonte, M., & Carraro, U. (1998) · PubMed · Cited by 112
To the edge of cell death and back
Gong, Y., Crawford, J. C., Heckmann, B. L., & Green, D. R. (2018) · FEBS Journal · doi:10.1111/febs.14714 · Cited by 112
Pegoraro, E., Cianno, B. D., Hoffman, E. P., Mancías, P., Swerdlow, S. H., Raikow, R. B., García, C., Marks, H. G., Crawford, T. O., & Carver, V. H. (1996) · Annals of Neurology · doi:10.1002/ana.410400515 · Cited by 112
Conklin, L. S., Damsker, J. M., Hoffman, E. P., Jusko, W. J., Mavroudis, P. D., Schwartz, B. D., Mengle-Gaw, L. J., Smith, E. C., Mah, J. K., Guglieri, M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.007 · Cited by 111
Zhou, S., Zhang, W., Cai, G., Ding, Y., Wei, C., Li, S., Yu, Y., Qin, J., Liu, D., Zhang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00393-6 · Cited by 109 · cited 11×
“Necroptotic demise could therefore be an important mechanism of myofibre death which paves the way for the early phases of muscle regeneration [19].”
BackgroundInfluentialThorp, E., Subramanian, M., & Tabas, I. (2011) · European Journal of Immunology · doi:10.1002/eji.201141719 · Cited by 107
Giordano, C., Mojumdar, K., Liang, F., Lemaire, C. F., Li, T., Richardson, J., Divangahi, M., Qureshi, S. T., & Petrof, B. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu735 · Cited by 107 · cited 1×
“Interestingly, mdxTLR4−/− mice present a reduced diaphragm pathology, associated with histological evidence of reduced inflammatory infiltration and central nucleation [78].”
BackgroundFibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications
Serrano, A. L., & Muñoz‐Cánoves, P. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.09.013 · Cited by 106 · cited 1×
“An indirect consequence of chronic degeneration is the incapacity of myogenesis to fully compensate for myofibre loss, by accumulating scar tissue such as fibrosis and adipocytes, and participating in the loss of the contractile function [28].”
BackgroundMORPHOLOGICAL CHANGES IN DYSTROPHIC MUSCLE
Cullen, M. J., & Mastaglia, F. L. (1980) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071630 · Cited by 104 · cited 2×
“Dystrophic muscles also show an increased proportion of unusual atrophic or hypertrophic myofibres compared to healthy muscles, as a consequence of the significant remodelling process [21,22].”
BackgroundCardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo
Ownby, C. L., Fletcher, J. E., & Colberg, T. R. (1993) · Toxicon · doi:10.1016/0041-0101(93)90376-t · Cited by 104
Londhe, P., & Davie, J. K. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05397-11 · Cited by 104
Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy
Wein, N., Alfano, L. N., & Flanigan, K. M. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.03.008 · Cited by 104 · cited 1×
“However, about 70% of DMD patients show a mutation in the genomic hot spot region located between exons 45 and 53 [31,32].”
BackgroundA novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9
Sui, T., Lau, Y. S., Liu, D., Liu, T., Xu, L. M., Gao, Y., Lai, L., Li, Z., & Han, R. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.032201 · Cited by 99 · cited 1×
“These include mouse [36,37], dog [38], pig [39], rabbit [40], and rat [41–43] species.”
BackgroundCaspase 3 cleavage of Pax7 inhibits self-renewal of satellite cells
Dick, S. A., Chang, N. C., Dumont, N. A., Bell, R. A. V., Putinski, C., Kawabe, Y., Litchfield, D. W., Rudnicki, M. A., & Megeney, L. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512869112 · Cited by 92
Dubinin, M. V., Talanov, E. Y., Tenkov, K. S., Starinets, V. S., Mikheeva, I. B., Sharapov, M. G., & Belosludtsev, K. N. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165674 · Cited by 89
Dexamethasone Effects on Myoblast Proliferation and Differentiation*
Guerriero, V., & Florini, J. R. (1980) · Endocrinology · doi:10.1210/endo-106-4-1198 · Cited by 89
Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies
Kamiya, M., Mizoguchi, F., Kawahata, K., Wang, D., Nishibori, M., Day, J. A., Louis, C., Wicks, I. P., Kohsaka, H., & Yasuda, S. (2022) · Nature Communications · doi:10.1038/s41467-021-27875-4 · Cited by 86 · cited 2×
“In polymyositis, few myofibres are immunoreactive to antibodies directed against RIPK3 and MLKL, and myonecrosis is reduced in a mouse model for C protein-induced myositis depleted for MLKL and RIPK3 [20].”
BackgroundTWEAK and cIAP1 Regulate Myoblast Fusion Through the Noncanonical NF-κB Signaling Pathway
Enwere, E. K., Holbrook, J., Mrad, R. L., Vineham, J., Timusk, K., Sivaraj, B., Isaac, M. B., Uehling, D., Al‐awar, R., LaCasse, E. C., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2003086 · Cited by 85
Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS
Wang, T., Perera, N. D., Chiam, M. D. F., Cuic, B., Wanniarachchillage, N., Tomas, D., Samson, A. L., Cawthorne, W., Valor, E. N., Murphy, J. M., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0457-8 · Cited by 81
Adams, V., Gielen, S., Hambrecht, R., & Schuler, G. (2001) · Frontiers in bioscience · doi:10.2741/a589 · Cited by 80
Plant, D. R., Colarossi, F. E., & Lynch, G. S. (2006) · Muscle & Nerve · doi:10.1002/mus.20616 · Cited by 79
Markers of degeneration and regeneration in Duchenne muscular dystrophy.
Abdelsalam, E. M. N., Abdel-Meguid, I. E., & Korraa, S. S. (2009) · PubMed · Cited by 79
Dominov, J. A., Kravetz, A. J., Ardelt, M., Kostek, C. A., Beermann, M. L., & Miller, J. B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi095 · Cited by 76
Lamkanfi, M., & Dixit, V. M. (2017) · Nature · doi:10.1038/548534a · Cited by 76
Enwere, E. K., LaCasse, E. C., Adam, N., & Korneluk, R. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00034 · Cited by 76
Muscle‐fiber apoptosis in neuromuscular diseases
Tews, D. S. (2005) · Muscle & Nerve · doi:10.1002/mus.20348 · Cited by 75
LGMD. Identification, description and classification.
Angelini, C. I. (2020) · PubMed Central · doi:10.36185/2532-1900-024 · Cited by 74
Renjini, R., Gayathri, N., Nalini, A., & Bharath, M. M. S. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0683-z · Cited by 72 · cited 1×
“Reactive oxygen species (ROS) are often associated with myofibre death [25,26], even if their precise role in pathogenesis remains unclear as ROS can be generated by cells submitted to sublethal or lethal stress [27].”
BackgroundDownregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
Boursereau, R., Abou-Samra, M., Lecompte, S., Noel, L., & Brichard, S. M. (2018) · BMC Biology · doi:10.1186/s12915-018-0501-z · Cited by 72
Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy
Schiavone, M., Zulian, A., Menazza, S., Petronilli, V., Argenton, F., Merlini, L., Sabatelli, P., & Bernardi, P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.001 · Cited by 71
Prednisone can protect against exercise-induced muscle damage
Jacobs, S. C. J. M., Bootsma, A. L., Willems, P. W. A., B�r, P. D. P. R., & Wokke, J. H. J. (1996) · Journal of Neurology · doi:10.1007/bf00869001 · Cited by 68
BAX and BAK dynamics control mitochondrial DNA release during apoptosis
Yamazaki, T., & Galluzzi, L. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00985-2 · Cited by 64
Passaquin, A., Metzinger, L., Leger, J. J., Warter, J., & Poindron, P. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350403 · Cited by 60
Oláh, G., Szczęsny, B., Brunyánszki, A., López-García, I. A., Gerő, D., Radak, Z. O., & Szabó, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134227 · Cited by 59
Apoptosome-dependent myotube formation involves activation of caspase-3 in differentiating myoblasts
Dehkordi, M. H., Tashakor, A., O’Connell, E., & Fearnhead, H. O. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2502-4 · Cited by 56
Stretch-activated cation channels in skeletal muscle myotubes from sarcoglycan-deficient hamsters
Nakamura, T. Y., Iwata, Y., Sampaolesi, M., Hanada, H., Saito, N., Artman, M., Coetzee, W. A., & Shigekawa, M. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.2.c690 · Cited by 55 · cited 1×
“6 myotubes from δ-SG-deficient hamsters with basal increased opening probabilities and decreased closed times [95], which is mediated by transient receptor potential cation channel subfamily V, member 2 (TRPV2) [96].”
BackgroundJones, T. I., Chew, G.-L., Barraza‐Flores, P., Schreier, S., Ramirez, M., Wuebbles, R. D., Burkin, D. J., Bradley, R. K., & Jones, P. L. (2020) · Skeletal Muscle · doi:10.1186/s13395-020-00227-4 · Cited by 55
Zabłocka, B., Górecki, D. C., & Zabłocki, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011040 · Cited by 54 · cited 1×
“A hallmark of dystrophin-deficient cells is the dysregulation of calcium homeostasis and an increase of cytosolic calcium levels, with consequences on the activation of protease systems such as calpains [13,79].”
BackgroundTaglietti, V., Kefi, K., Bronisz-Budzyńska, I., Mirciloglu, B., Rodrigues, M., Cardone, N., Coulpier, F., Periou, B., Gentil, C., Goddard, M. A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01355-2 · Cited by 53 · cited 1×
“RIPK1 and RIPK3 are upregulated in DMD rats, which develop a significant cardiomyopathy [43,186].”
BackgroundYao, W., Li, H., Han, X., Chen, C., Zhang, Y., Tai, W. L., Xia, Z., & Hei, Z. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13171 · Cited by 51
The carcinogenicity of ciclosporin
Ryffel, B. (1992) · Toxicology · doi:10.1016/0300-483x(92)90166-c · Cited by 51
Xiao, R., Ferry, A. L., & Dupont‐Versteegden, E. E. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0566-9 · Cited by 50
Characterization of the ATP-hydrolysing activity of α-sarcoglycan
Sandonà, D., Gastaldello, S., Martinello, T., & Betto, R. (2004) · Biochemical Journal · doi:10.1042/bj20031644 · Cited by 50
Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo
Dermentzaki, G., Politi, K. A., Lü, L., Mishra, V. R., Pérez-Torres, E. J., Sosunov, A. A., McKhann, G. M., Lotti, F., Shneider, N. A., & Przedborski, S. (2019) · eNeuro · doi:10.1523/eneuro.0308-18.2018 · Cited by 49
Kesari, A., Fukuda, M., Knoblach, S. M., Bashir, R., Nader, G. A., Rao, D. A., Nagaraju, K., & Hoffman, E. P. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080098 · Cited by 49
Cyclosporine immunosuppression
Canafax, D. M., & Ascher, N. L. (1984) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/41.1.178 · Cited by 48
A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
Gawlik, K. I., & Durbeej, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00059 · Cited by 44
Lagrota-Cândido, J., Vasconcellos, R., Cavalcanti, M. G., Bozza, M. T., Savino, W., & Quírico‐Santos, T. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00221.x · Cited by 41
Tzeng, H.-P., Evans, S., Gao, F., Chambers, K. T., Topkara, V. K., Sivasubramanian, N., Barger, P. M., & Mann, D. L. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000662 · Cited by 37
Israeli, D., Cosette, J., Corre, G., Amor, F., Poupiot, J., Stockholm, D., Montus, M., Gjata, B., & Richard, I. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.04.007 · Cited by 36
Cited by
Tejedera‐Villafranca, A., Montolio, M., Ramón‐Azcón, J., & Fernández‐Costa, J. M. (2023) · Biofabrication · doi:10.1088/1758-5090/acfb3d · Cited by 21
“This represents a significant milestone as it provides an opportunity to explore the replication of additional manifestations of DMD stemming from a sarcolemmal injury, thereby initiating cellular degeneration and eventual muscle wasting [51].”
BackgroundNieves‐Rodriguez, S., Barthélémy, F., Woods, J. D., Douine, E. D., Wang, R. T., Scripture-Adams, D. D., Chesmore, K. N., Galasso, F. I., Miceli, M. C., & Nelson, S. F. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1216066 · Cited by 19
“Myofiber death in DMD has been mainly attributed to necrosis (Bencze, 2023).”
BackgroundKirby, T. J., Zahr, H. C., Fong, E. H. H., & Lammerding, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01998-1 · Cited by 14
“For ex vivo contraction studies, post-mortem tissue was obtained from animals sacri fi ced for other approved research projects and/or breeding surplus of the VU University in accordance with the European Council Directive (2010/63/EU) by permission of the Animal Research Law of the Netherlands.”
MethodThe Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis
Russo, C., Surdo, S., Valle, M. S., & Malaguarnera, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011310 · Cited by 12
“In the early stages, due to the regenerative capabilities of muscle fibers, the microlesions may be associated with pseudo-muscle hypertrophy, especially in postural muscles such as the sural triceps [55].”
BackgroundBencze, M., Periou, B., Punzón, I., Barthélémy, I., Taglietti, V., Hou, C., Zaidan, L. R., Kefi, K., Blot, S., Agbulut, O., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13265 · Cited by 10
Self-citation
Metadata
- Authors
- Bencze, M.
- Affiliations
- Inserm (FR)
- Corresponding author
- Bencze, Maximilien
- ORCID
- Bencze, Maximilien
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-26
- Volume
- 24
- Issue
- 1
- Pages
- 362
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9820579
- OpenAlex
- W4313245546
- Cited by
- 20
- References
- 232
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 3 · 2023: 5
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Association Française contre les Myopathies (AFM-Téléthon) (#19507, #22946)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- muscular dystrophy, regulated cell death, necroptosis, apoptosis, Duchenne muscular dystrophy, muscle degeneration, muscle regeneration, muscle necrosis, interstitial fibrosis
- MeSH terms
- Humans, Necrosis, Apoptosis, Muscle, Skeletal, Muscular Dystrophy, Duchenne
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.